Lupin gets FDA okay for generic triamcinolone acetonide ointment

Press enter to search
Close search
Open Menu

Lupin gets FDA okay for generic triamcinolone acetonide ointment

By Sandra Levy - 10/22/2018
Lupin has been granted the Food and Drug Administration’s approval for its triamcinolone acetonide ointment 0.1%.

The product is a generic version of Mylan Pharmaceuticals’ triamcinolone acetonide ointment 0.1%.

It is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Triamcinolone acetonide ointment 0.1% had a market value of approximately $25.7 million, according to June 2018 IQVIA data.

RELATED TOPICS